Questcor (QCOR -5.7%) can't catch a break. Shares are diving yet again after a presentation...
Questcor (QCOR -5.7%) can't catch a break. Shares are diving yet again after a presentation (.pdf) from Chief Scientific Officer David Young at a JMP conference failed to soothe fears stoked by a brutal Citron Research report on Tuesday. While discussing how Questcor's Acthar gel is differentiated, Young's review of the history of generic/third-party alternatives (page 11) may have done more harm than good. Questcor is down 25% from Monday's close.
From other sites
at Nasdaq.com (Apr 9, 2015)
at Zacks.com (Mar 24, 2015)
at Zacks.com (Mar 6, 2015)
at Nasdaq.com (Mar 3, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs